Sendero Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.25M Sell
37,641
-3,809
-9% -$317K 0.32% 52
2026
Q2
$2.79M Sell
41,450
-13,560
-25% -$903K 0.28% 63
2026
Q1
$3.45M Sell
55,010
-10,664
-16% -$743K 0.38% 52
2025
Q4
$4.36M Sell
65,674
-1,749
-3% -$113K 0.48% 44
2025
Q3
$4.54M Buy
67,423
+31,094
+86% +$2.46M 0.53% 39
2025
Q2
$3.17M Buy
36,329
+25,710
+242% +$2.02M 0.4% 53
2025
Q1
$725K Buy
+10,619
New +$867K 0.1% 118

Other funds holding DXCM

Sendero Wealth Management's DXCM Position: Q3 2026 in Review

Sendero Wealth Management reduced its DexCom (DXCM) stake by 9.2% in Q3 2026, selling an estimated $317K and leaving 37,641 shares worth $3.25M. The position accounts for 0.32% of the portfolio, ranked #52.

Sendero Wealth Management first reported a position in DXCM in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.54M in Q3 2025. 230 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Sendero Wealth Management held 37,641 shares of DexCom worth $3.25M as of Q3 2026.
  • Sendero Wealth Management sold 3,809 DexCom shares in Q3 2026, an estimated $317K.
  • DexCom made up 0.32% of Sendero Wealth Management's portfolio in Q3 2026, its #52 holding.
  • Sendero Wealth Management first reported a position in DexCom in Q1 2025 and has held it in 7 quarters since.
  • Sendero Wealth Management's DexCom position peaked at $4.54M in Q3 2025.
  • 230 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Sendero Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.